/
/
/

Sandu Pharmaceuticals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012
₹16 Cr₹17 Cr₹19 Cr₹18 Cr₹17 Cr₹14 Cr₹18 Cr₹18 Cr₹17 Cr₹16 Cr₹17 Cr₹17 Cr₹18 Cr₹15 Cr₹17 Cr₹17 Cr₹16 Cr₹11 Cr₹19 Cr₹18 Cr₹17 Cr₹14 Cr₹16 Cr₹17 Cr₹12 Cr₹11 Cr₹13 Cr₹12 Cr₹12 Cr₹12 Cr₹14 Cr₹12 Cr₹11 Cr₹12 Cr₹11 Cr₹17 Cr₹7 Cr₹11 Cr₹11 Cr₹12 Cr₹10 Cr₹11 Cr₹11 Cr₹10 Cr₹9 Cr₹11 Cr₹10 Cr₹10 Cr₹8 Cr₹10 Cr₹9 Cr₹9 Cr₹8 Cr₹9 Cr₹8 Cr₹7 Cr
₹2 L₹37 L₹1 L₹5 L₹2 L₹7 L₹3 L₹3 L₹5 L₹31 L₹3 L₹9 L₹10,000₹5 L₹3 L₹17 L₹9 L₹3 L₹40,000₹3 L₹2 L₹3 L₹7 L₹7 L₹2 L₹4 L₹13 L₹14 L₹14 L₹14 L₹12 L₹12 L₹19 L₹8 L₹80,000-₹2 L₹5 L₹2 L₹40 L₹5 L₹30,000₹8 L₹70,000₹3 L₹4 L₹6 L₹4 L₹2 L₹3 L₹15 L₹9 L₹4 L₹4 L₹23 L₹5 L₹3 L
₹16 Cr₹17 Cr₹19 Cr₹18 Cr₹17 Cr₹14 Cr₹18 Cr₹18 Cr₹17 Cr₹16 Cr₹17 Cr₹17 Cr₹18 Cr₹15 Cr₹17 Cr₹17 Cr₹16 Cr₹11 Cr₹19 Cr₹18 Cr₹17 Cr₹14 Cr₹16 Cr₹17 Cr₹12 Cr₹11 Cr₹13 Cr₹12 Cr₹12 Cr₹12 Cr₹14 Cr₹12 Cr₹11 Cr₹12 Cr₹11 Cr₹17 Cr₹7 Cr₹11 Cr₹12 Cr₹12 Cr₹10 Cr₹11 Cr₹11 Cr₹10 Cr₹9 Cr₹11 Cr₹10 Cr₹10 Cr₹8 Cr₹10 Cr₹9 Cr₹9 Cr₹8 Cr₹9 Cr₹8 Cr₹7 Cr
₹16 Cr₹16 Cr₹18 Cr₹17 Cr₹16 Cr₹14 Cr₹18 Cr₹17 Cr₹17 Cr₹15 Cr₹17 Cr₹16 Cr₹17 Cr₹15 Cr₹16 Cr₹16 Cr₹16 Cr₹11 Cr₹19 Cr₹17 Cr₹17 Cr₹13 Cr₹15 Cr₹17 Cr₹12 Cr₹11 Cr₹13 Cr₹11 Cr₹12 Cr₹12 Cr₹14 Cr₹12 Cr₹11 Cr₹12 Cr₹10 Cr₹17 Cr₹7 Cr₹11 Cr₹10 Cr₹11 Cr₹10 Cr₹11 Cr₹10 Cr₹10 Cr₹8 Cr₹11 Cr₹10 Cr₹9 Cr₹8 Cr₹9 Cr₹9 Cr₹9 Cr₹7 Cr₹8 Cr₹7 Cr₹7 Cr
₹56 L₹94 L₹1 Cr₹91 L₹54 L₹52 L₹1 Cr₹95 L₹45 L₹91 L₹54 L₹91 L₹36 L₹53 L₹85 L₹1 Cr₹41 L₹60 L₹77 L₹83 L₹76 L₹85 L₹57 L₹66 L₹27 L₹32 L₹44 L₹61 L₹54 L₹52 L₹58 L₹80 L₹77 L₹92 L₹97 L₹81 L-₹12 L-₹57 L₹1 Cr₹1 Cr₹71 L₹94 L₹85 L₹59 L₹64 L₹48 L₹79 L₹75 L₹59 L₹80 L₹58 L₹48 L₹57 L₹70 L₹55 L₹61 L
₹3 L₹3 L₹3 L₹3 L₹3 L₹3 L₹3 L₹3 L₹2 L₹70,000₹2 L₹2 L₹2 L₹2 L₹2 L₹2 L₹2 L₹2 L₹30,000₹5 L₹4 L₹6 L₹1 L-₹3 L₹7 L₹10 L₹8 L₹12 L₹14 L₹19 L₹24 L₹33 L₹25 L₹28 L₹30 L₹34 L₹31 L₹32 L₹36 L₹41 L₹40 L₹42 L₹45 L₹43 L₹34 L₹34 L₹32 L₹37 L₹34 L₹26 L₹30 L₹26 L₹23 L₹12 L₹18 L₹16 L
₹36 L₹75 L₹86 L₹72 L₹34 L₹34 L₹80 L₹74 L₹27 L₹72 L₹38 L₹77 L₹21 L₹38 L₹70 L₹88 L₹26 L₹45 L₹63 L₹65 L₹59 L₹66 L₹42 L₹54 L₹6 L₹8 L₹22 L₹35 L₹27 L₹17 L₹18 L₹31 L₹36 L₹40 L₹55 L₹35 L-₹54 L-₹1 Cr₹71 L₹57 L₹14 L₹19 L₹28 L₹4 L₹17 L₹3 L₹31 L₹22 L₹10 L₹38 L₹14 L₹15 L₹14 L₹49 L₹26 L₹32 L
₹23 L₹4 L₹98 L₹53 L₹22 L₹33 L₹56 L₹50 L₹17 L₹59 L₹21 L₹55 L₹11 L₹27 L₹48 L₹60 L₹17 L₹27 L₹45 L₹45 L₹42 L₹46 L₹29 L₹40 L₹4 L₹17 L₹16 L₹23 L₹31 L₹1 L₹8 L₹21 L₹33 L₹30 L₹38 L₹35 L-₹54 L-₹1 Cr₹38 L₹55 L₹6 L₹18 L₹22 L₹1 L₹13 L-₹5 L₹24 L₹15 L₹11 L₹17 L₹11 L₹10 L₹11 L₹30 L₹16 L₹27 L

Share Price Live Stats

Open (₹)38.99
Volume (₹)9,407.00
High (₹)38.99
Upper Circuit45.74
Low (₹)37.00
Lower Circuit30.50
Prev Close39.12
52W High (₹)50.50
Price38.26
52W Low (₹)30.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)37.79 Cr
Div. Yield (%)2.56
PE Ratio21.34
Debt to Equity0.00
Price to Book0.84
Book Value36.48
EPS (TTM)1.83
Face Value10.00
ROE (%)5.14

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
SANDUPHQ-XNSE
LTP
1W Low
1W High
Market cap (₹)
1899.85-20.25 (-1.05%)
1896.30
1964.85
4,56,833Cr
9137-132 (-1.42%)
9051.85
9296
2,45,426Cr
4837.35-197.65 (-3.93%)
4822.25
5049
1,87,320Cr
1130.4-56.6 (-4.77%)
1126
1191.45
1,13,217Cr
1380.6-37.4 (-2.64%)
1376
1426.20
1,12,212Cr
1843.8-91.5 (-4.73%)
1812
1947.90
1,01,155Cr
2109.55-65.45 (-3.01%)
2107.35
2209
97,626Cr
2331.35-56.05 (-2.35%)
2323.15
2407.40
96,859Cr
1157-20.8 (-1.77%)
1155
1179.90
96,406Cr
1653.55+3.55 (0.22%)
1623.05
1706.70
93,614Cr
38.26+0.06 (0.16%)
36.06
39.50
38Cr

Key Highlights of Sandu Pharmaceuticals Ltd’s P&L

In 2025-03-31, Sandu Pharmaceuticals Ltd reported total revenue of ₹67.36Cr, compared with ₹67.7Cr in 2024-03-31, reflecting Sandu Pharmaceuticals Ltd turnover.

Depreciation was ₹67.06Lakh and finance costs were ₹10.33Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹2.16Cr in 2025-03-31 as compared to ₹2.07Cr in 2024-03-31.

Net Profit (PAT) was ₹1.55Cr in 2025-03-31 compared with ₹1.46Cr in 2024-03-31.

Earnings per share (EPS) were ₹1.61 in 2025-03-31, compared with ₹1.51 in 2024-03-31.